| Date | Research Question / Title | Unique ID | Research Team |
|---|---|---|---|
| March 31, 2022 | What is the efficacy of a 4th booster dose for COVID-19? | EOC220304 RR | EOC |
| March 10, 2022 | What is the safety/efficacy of the Novavax COVID-19 vaccine? | EOC220302 RR | EOC |
| February 4, 2022 | What are the harmful/adverse effects of multiple doses of COVID-19 mRNA vaccines? | EOC220103 RR | EOC |
| December 26, 2021 | How effective are COVID-19 vaccines? [Evergreen] | INF031801v019 RR | Infectious Disease |
| April 21, 2021 | What are the risks or benefits of extended intervals between doses of COVID-19 vaccines compared to recommended dosing in extremely vulnerable populations? | EOC210302 RR | EOC |
| March 18, 2021 | What are the differences between COVID-19 vaccines and how should they be distributed based on population group(s)? | EOC031001 RR | EOC |
| January 19, 2021 | How are other jurisdictions distributing COVID-19 vaccines in non-healthcare worker environments and what is the rationale for those distribution models? | PH011401 RR | Public Health |
